Is pre-radiotherapy metabolic heterogeneity of glioblastoma predictive of progression-free survival?
Tensaouti F, Desmoulin F, Gilhodes J, Roques M, Ken S, Lotterie JA, Noël G, Truc G, Sunyach MP, Charissoux M, Magné N, Lubrano V, Péran P, Cohen-Jonathan Moyal E, Laprie A.
Tensaouti F, et al. Among authors: lubrano v.
Radiother Oncol. 2023 Jun;183:109665. doi: 10.1016/j.radonc.2023.109665. Epub 2023 Apr 5.
Radiother Oncol. 2023.
PMID: 37024057